PRECLINICAL DEVELOPMENT OF MICRO-TUBERIN GENE THERAPY FOR TUBEROUS SCLEROSIS COMPLEX TYPE 2

$703,000FY2025Defense Health AgencyDOD

Research Institute At Nationwide Children'S Hospital

Investigators